Form 8-K - Current report:
SEC Accession No. 0001625297-25-000078
Filing Date
2025-12-22
Accepted
2025-12-22 07:03:43
Documents
14
Period of Report
2025-12-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K indv-20251222.htm   iXBRL 8-K 26886
2 EX-99.1 ex991sp600.htm EX-99.1 8976
6 GRAPHIC image_0.jpg GRAPHIC 147383
  Complete submission text file 0001625297-25-000078.txt   355526

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indv-20251222.xsd EX-101.SCH 1773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indv-20251222_lab.xml EX-101.LAB 21615
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indv-20251222_pre.xml EX-101.PRE 12502
16 EXTRACTED XBRL INSTANCE DOCUMENT indv-20251222_htm.xml XML 2738
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Filer) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37835 | Film No.: 251589417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)